Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Tablets × Gastrointestinal × Clear all

Phase

Status

Not yet recruiting 3 Completed 3 Unknown 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 3 Plasma cell 1 Lymphoid 1 Head & Neck 1 Gynecologic 1 Gastrointestinal 1 Dermatologic 1

Conditions

Rectal Neoplasms 1

Interventions

Oxaliplatin 102 Fluorouracil 90 Gemcitabine 79 Capecitabine 77 Leucovorin 75 Nivolumab 72 pembrolizumab 64 Bevacizumab 59 Magnetic Resonance Spectroscopy 53 Irinotecan 51 Specimen Handling 49 durvalumab 47 Cisplatin 42 Radiotherapy 41 Paclitaxel 39 atezolizumab 38 Biopsy 38 130-nm albumin-bound paclitaxel 36 Taxes 29 Cetuximab 29 Carboplatin 29 Albumin-Bound Paclitaxel 29 dehydroftorafur 23 tislelizumab 21 Ipilimumab 20 Drug Therapy 20 Radiation 18 Docetaxel 18 trifluridine tipiracil drug combination 16 regorafenib 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04503694 2026-03-27

REGINA

Jules Bordet Institute

Phase 2 Active not recruiting

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡